Niacin
Product Images NDC 10135-613

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Niacin (NDC 10135-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Niacin Extended-release Tablets Are Unscored, Film-coated Tablets For Oral Administration And Are Available In Two Tablet Strengths Containing 500 mg And 1000 mg Niacin. (Niacin Extended Release 01)

This appears to be a chemical composition description. The compound has a carboxylic acid (COOH) group and a molecular weight (MW) of 123.11 g/mol. The other characters (CsHsNO) may represent the chemical formula of a functional group within the compound, but without more information it is difficult to determine its exact identity.*

FDA Label Image

Principal Display Panelndc 10135-0612-90marlexniacinextended- Release Tablets500 mgrx Only90 Tablets (Niacin Extended Release 02)

This text is a medication label that provides instructions for pharmacists on how to dispense Niacin Extended-Release Tablets. It includes information on the usual dosage, storage, and container requirements, as well as details on the tablet contents, packaging, and distribution. It also warns against accepting tablets with a broken seal over the bottle opening.*

FDA Label Image

Principal Display Panelndc 10135-0613-90marlexniacinextended- Release Tablets750 mgrx Only90 Tablets (Niacin Extended Release 03)

This is a medication information sheet for Niacin Extended-Release Tablets, manufactured by Marlex Pharmaceuticals. It contains instructions for dispensing, storage, and dosing, as well as the medication's ingredients and the manufacturer's contact information. The sheet requests that the pharmacist not attach patient information to the package insert. It also specifies that the medication should be dispensed in a container with a child-resistant closure and should not be accepted if the bottle seal is broken or missing. Lot number and expiration date is also specified.*

FDA Label Image

Principal Display Panelndc 10135-0614-90marlexniacinextended- Release Tablets1000 mgrx Only90 Tablets (Niacin Extended Release 04)

This is a prescription medication for Niacin extended-release tablets. The usual dosage information can be found in the package insert. The pharmacist is instructed to dispense the medication in a tight container with a child-resistant closure and to not accept if the seal is broken or missing. The medication should be stored at room temperature. The medication package contains 90 tablets and has an NDC number of 10135-0614-90. The tablets are manufactured and distributed by Marlex Pharmaceuticals. Lot number and expiration date information is also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.